Results of risk analysis suggested that LINC00968, LINC00663, and ITGA9-AS1 have the potential to serve as anti-tumor regulators in LUAD, conversely, LINC00857 was identified as a risk factor. The gene discussed is ITGA9; the disease is neoplasm.